Atlas Trials

Maintaining ERBB Blockade in EGFR-mutated Lung Cancer

Clinical trial NCT02488694 · TERMINATED

Trial details

NCT number
NCT02488694
Sponsor
AIO-Studien-gGmbH
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small-cell Lung Cancer With Somatic EGFR Mutations
Start date
2015-11-01
Primary completion
2017-12-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.